Abstract
Changes in the interactions among the gut microbiota, intestinal epithelium, and host immune system are associated with many diseases, including cancer. We discuss how environmental factors influence this cross-talk during oncogenesis and tumor progression and how manipulations of the gut microbiota might improve the clinical activity of anticancer agents.
Original language | English |
---|---|
Article number | 271ps1 |
Journal | Science Translational Medicine |
Volume | 7 |
Issue number | 271 |
DOIs | |
State | Published - Jan 21 2015 |
Externally published | Yes |